Effects of prior antiplatelet use on futile reperfusion in patients with acute ischemic stroke receiving endovascular treatment

被引:3
作者
Sohn, Jong-Hee [1 ,2 ]
Kim, Chulho [1 ,2 ]
Lee, Minwoo [3 ]
Kim, Yerim [4 ]
Mo, Hee Jung [5 ]
Yu, Kyung-Ho [3 ]
Lee, Sang-Hwa [1 ,2 ,6 ]
机构
[1] Hallym Univ, Chuncheon Sacred Heart Hosp, Coll Med, Dept Neurol, Chunchon, South Korea
[2] Hallym Univ, Inst New Frontier Res Team, Chunchon, South Korea
[3] Hallym Univ, Hallym Sacred Heart Hosp, Coll Med, Dept Neurol, Anyang, South Korea
[4] Hallym Univ, Kangdong Sacred Heart Hosp, Coll Med, Dept Neurol, Seoul, South Korea
[5] Hallym Univ, Dongtan Sacred Heart Hosp, Coll Med, Dept Neurol, Hwaseong, South Korea
[6] Hallym Univ, Chuncheon Sacred Heart Hosp, Coll Med, Dept Neurol, 77 Sakju Ro, Chunchon 24253, GangwonmDo, South Korea
基金
新加坡国家研究基金会;
关键词
Prior APU; futile reperfusion; endovascular treatment; hemorrhagic transformation; HEALTH-CARE PROFESSIONALS; BLOOD-BRAIN-BARRIER; HEMORRHAGIC TRANSFORMATION; THROMBECTOMY; CLOT; ALTEPLASE; ASPIRIN; THERAPY;
D O I
10.1177/23969873221144814
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: We evaluated the effects of prior antiplatelet use (APU) on futile reperfusion (FR) after endovascular treatment (EVT) in acute ischemic stroke. Material and methods: We consecutively collected data of 9369 patients with acute ischemic stroke from four university-affiliated multicenter registry databases over 92 months. We enrolled 528 patients with acute stroke receiving EVT. Among them, we defined FR in subjects as a 3-month modified Rankin Scale score of >2 despite successful reperfusion after EVT. We classified patients into two groups: prior APU and no prior APU. We used propensity score matching (PSM) to overcome the imbalance in multiple covariates between the two groups. After PSM, we compared the baseline characteristics between the two groups and performed multivariate analysis to determine whether prior APU affected FR and other stroke outcomes. Results: The overall FR rate in the present study was 54.2%. In the PSM cohort, the FR was lower in the prior APU group than that in the no prior APU group (66.2% vs 41.5%, p < 0.001). In the multivariate analysis using the PSM cohort, prior APU significantly reduced the risk of FR (odds ratio (OR), 0.32; 95% confidence interval (CI), 0.18-0.55; p = 0.001) and stroke progression (OR, 0.38; 95% CI, 0.15-0.93; p = 0.03). Prior APU was not associated with symptomatic hemorrhagic transformation in this study. Conclusion: Prior APU potentially reduced FR and stroke progression. Further, prior APU was not associated with symptomatic hemorrhagic transformation in patients receiving EVT. APU pretreatment can be a modifiable predictor of FR in clinical practice.
引用
收藏
页码:208 / 214
页数:7
相关论文
共 36 条
[1]   Effects of Aspirin on Clot Structure and Fibrinolysis Using a Novel In Vitro Cellular System [J].
Ajjan, R. A. ;
Standeven, K. F. ;
Khanbhai, M. ;
Phoenix, F. ;
Gersh, K. C. ;
Weisel, J. W. ;
Kearney, M. T. ;
Ariens, R. A. S. ;
Grant, P. J. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (05) :712-U196
[2]   Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging [J].
Albers, G. W. ;
Marks, M. P. ;
Kemp, S. ;
Christensen, S. ;
Tsai, J. P. ;
Ortega-Gutierrez, S. ;
McTaggart, R. A. ;
Torbey, M. T. ;
Kim-Tenser, M. ;
Leslie-Mazwi, T. ;
Sarraj, A. ;
Kasner, S. E. ;
Ansari, S. A. ;
Yeatts, S. D. ;
Hamilton, S. ;
Mlynash, M. ;
Heit, J. J. ;
Zaharchuk, G. ;
Kim, S. ;
Carrozzella, J. ;
Palesch, Y. Y. ;
Demchuk, A. M. ;
Bammer, R. ;
Lavori, P. W. ;
Broderick, J. P. ;
Lansberg, M. G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (08) :708-718
[3]   Endovascular procedures cause transient endothelial injury but do not disrupt mature neointima in Drug Eluting Stents [J].
Autar, Anouchska ;
Taha, Aladdin ;
van Duin, Richard ;
Krabbendam-Peters, Ilona ;
Duncker, Dirk J. ;
Zijlstra, Felix ;
van Beusekom, Heleen M. M. .
SCIENTIFIC REPORTS, 2020, 10 (01)
[4]   A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke [J].
Berkhemer, O. A. ;
Fransen, P. S. S. ;
Beumer, D. ;
van den Berg, L. A. ;
Lingsma, H. F. ;
Yoo, A. J. ;
Schonewille, W. J. ;
Vos, J. A. ;
Nederkoorn, P. J. ;
Wermer, M. J. H. ;
van Walderveen, M. A. A. ;
Staals, J. ;
Hofmeijer, J. ;
van Oostayen, J. A. ;
Nijeholt, G. J. Lycklama A. ;
Boiten, J. ;
Brouwer, P. A. ;
Emmer, B. J. ;
de Bruijn, S. F. ;
van Dijk, L. C. ;
Kappelle, L. J. ;
Lo, R. H. ;
Van Dijk, E. J. ;
de Vries, J. ;
de Kort, P. L. M. ;
van Rooij, W. J. J. ;
van den Berg, J. S. P. ;
van Hasselt, B. A. A. M. ;
Aerden, L. A. M. ;
Dallinga, R. J. ;
Visser, M. C. ;
Bot, J. C. J. ;
Vroomen, P. C. ;
Eshghi, O. ;
Schreuder, T. H. C. M. L. ;
Heijboer, R. J. J. ;
Keizer, K. ;
Tielbeek, A. V. ;
den Hertog, H. M. ;
Gerrits, D. G. ;
van den Berg-Vos, R. M. ;
Karas, G. B. ;
Steyerberg, E. W. ;
Flach, H. Z. ;
Marquering, H. A. ;
Sprengers, M. E. S. ;
Jenniskens, S. F. M. ;
Beenen, L. F. M. ;
van den Berg, R. ;
Koudstaal, P. J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (01) :11-20
[5]   The Impact of Histological Clot Composition in Embolic Stroke [J].
Boeckh-Behrens, T. ;
Schubert, M. I. ;
Foerschler, A. ;
Prothmann, S. ;
Kreiser, K. ;
Zimmer, C. ;
Riegger, J. ;
Bauer, J. ;
Neff, F. ;
Kehl, V. ;
Pelisek, J. ;
Schirmer, L. ;
Mehr, M. ;
Poppert, H. .
CLINICAL NEURORADIOLOGY, 2016, 26 (02) :189-197
[6]   Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection [J].
Campbell, B. C. V. ;
Mitchell, P. J. ;
Kleinig, T. J. ;
Dewey, H. M. ;
Churilov, L. ;
Yassi, N. ;
Yan, B. ;
Dowling, R. J. ;
Parsons, M. W. ;
Oxley, T. J. ;
Wu, T. Y. ;
Brooks, M. ;
Simpson, M. A. ;
Miteff, F. ;
Levi, C. R. ;
Krause, M. ;
Harrington, T. J. ;
Faulder, K. C. ;
Steinfort, B. S. ;
Priglinger, M. ;
Ang, T. ;
Scroop, R. ;
Barber, P. A. ;
McGuinness, B. ;
Wijeratne, T. ;
Phan, T. G. ;
Chong, W. ;
Chandra, R. V. ;
Bladin, C. F. ;
Badve, M. ;
Rice, H. ;
de Villiers, L. ;
Ma, H. ;
Desmond, P. M. ;
Donnan, G. A. ;
Davis, S. M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (11) :1009-1018
[7]   Neutrophils Obstructing Brain Capillaries Are a Major Cause of No-Reflow in Ischemic Stroke [J].
El Amki, Mohamad ;
Glueck, Chaim ;
Binder, Nadine ;
Middleham, William ;
Wyss, Matthias T. ;
Weiss, Tobias ;
Meister, Hanna ;
Luft, Andreas ;
Weller, Michael ;
Weber, Bruno ;
Wegener, Susanne .
CELL REPORTS, 2020, 33 (02)
[8]   Dynamic capillary stalls in reperfused ischemic penumbra contribute to injury: A hyperacute role for neutrophils in persistent traffic jams [J].
Erdener, Sefik E. ;
Tang, Jianbo ;
Kilic, Kivilcim ;
Postnov, Dmitry ;
Giblin, John T. ;
Kura, Sreekanth ;
Chen, I-Chun A. ;
Vayisoglu, Tugberk ;
Sakadzic, Sava ;
Schaffer, Chris B. ;
Boas, David A. .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2021, 41 (02) :236-252
[9]   Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke [J].
Goyal, M. ;
Demchuk, A. M. ;
Menon, B. K. ;
Eesa, M. ;
Rempel, J. L. ;
Thornton, J. ;
Roy, D. ;
Jovin, T. G. ;
Willinsky, R. A. ;
Sapkota, B. L. ;
Dowlatshahi, D. ;
Frei, D. F. ;
Kamal, N. R. ;
Montanera, W. J. ;
Poppe, A. Y. ;
Ryckborst, K. J. ;
Silver, F. L. ;
Shuaib, A. ;
Tampieri, D. ;
Williams, D. ;
Bang, O. Y. ;
Baxter, B. W. ;
Burns, P. A. ;
Choe, H. ;
Heo, J. -H. ;
Holmstedt, C. A. ;
Jankowitz, B. ;
Kelly, M. ;
Linares, G. ;
Mandzia, J. L. ;
Shankar, J. ;
Sohn, S. -I. ;
Swartz, R. H. ;
Barber, P. A. ;
Coutts, S. B. ;
Smith, E. E. ;
Morrish, W. F. ;
Weill, A. ;
Subramaniam, S. ;
Mitha, A. P. ;
Wong, J. H. ;
Lowerison, M. W. ;
Sajobi, T. T. ;
Hill, M. D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (11) :1019-1030
[10]   Does Current Oral Antiplatelet Agent or Subtherapeutic Anticoagulation Use Have an Effect on Tissue-Plasminogen-Activator-Mediated Recanalization Rate in Patients with Acute Ischemic Stroke? [J].
Ibrahim, Mohamed M. ;
Sebastian, Joseph ;
Hussain, Muhammad ;
Al-Hussain, Fawaz ;
Uchino, Ken ;
Molina, Carlos ;
Khan, Khurshid ;
Demchuk, Andrew M. ;
Alexandrov, Andrei V. ;
Saqqur, Maher .
CEREBROVASCULAR DISEASES, 2010, 30 (05) :508-513